一品红(300723.SZ)：子公司获得艾司奥美拉唑镁肠溶干混悬剂注册证书

Core Viewpoint - The company Yipinhong (300723.SZ) has received approval from the National Medical Products Administration for the drug registration certificate of Esomeprazole Magnesium Enteric-coated Suspension, indicating a significant advancement in its product portfolio [1] Group 1: Product Development - Yipinhong's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has recently obtained the drug registration certificate for Esomeprazole Magnesium Enteric-coated Suspension [1] - Esomeprazole is a proton pump inhibitor and the S-isomer of Omeprazole, specifically designed to inhibit gastric acid secretion by blocking the H+-K+ ATPase in gastric parietal cells [1] - The active ingredient of Esomeprazole is converted in the acidic environment of gastric parietal cells, effectively suppressing both basal and stimulated gastric acid secretion [1]